WELL Health Technologies has launched WELL Research, a new clinical research brand that offers full-service contract research organization (CRO) management, site management organization (SMO) services, and bioanalytical services across all clinical trial phases. This integrated platform leverages WELL's extensive outpatient clinic network, provider network, patient consent platform, and AI-driven feasibility and participant matching tools to improve trial participant recruitment and reliability. WELL Research aims to streamline clinical trials and become a significant growth driver for WELL by combining healthcare infrastructure with advanced technology. The initiative reflects WELL's strategy to enhance health outcomes by making clinical trials a specialized form of care for the right patients in the right settings.
WELL Health's launch of WELL Research is the story's subject, providing context for readers interested in health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Sep 22, 2026 14:11 WIB: Of 95 priced Health-sector US stocks tradable on Pluang, 43 rose and 48 fell today. Notable movers include HRTX (Heron Therapeutics Inc) at USD 0.30 with a 1-day change of +11.11% and a typical hold time of 34 days, DGX (Quest Diagnostics Inc) at USD 234.00 down 5.06% with a typical hold time of 55 days, and WGS (GeneDx Holdings Corp) at USD 97.00 down 4.06% with a typical hold time of 19 days and 100% buy order activity.
GoDaddy faces a class action lawsuit alleging securities fraud after its stock fell 14.28% due to claims it misrepresented its customer acquisition and go-to-market strategy. The lawsuit argues GoDaddy falsely promoted attracting high-value customers...
BFA Law is investigating Cardinal Infrastructure Group, Inc. for potential securities fraud related to misleading statements about the performance of its acquisition, A.L. Grading Contractors. The investigation follows a sharp 36% drop in Cardinal's ...
Hemlo Mining Corp. has updated its regional exploration strategy around the Hemlo Gold Mine after a detailed review by experts, including Dr. Richard Sillitoe and Dr. Ruben Padilla. The new approach interprets Hemlo as an Archean porphyry-epithermal ...
THOR Industries announced its fiscal 2026 results with net sales slightly up 0.3% to $9.61 billion but net income down 31.3% to $177.5 million due to margin pressures from inflation and higher costs. The company highlighted geographic diversification...
U.S. GoldMining Inc. has finished its 2026 exploration program at the Whistler Gold-Copper Project in Alaska, completing 7,493 meters of drilling across 17 holes in 10 target areas. This is the company's largest drilling effort to date, aiming to ide...
